Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
Price Target
Average
186.52%
Revenue Forecast
Estimate
54.10%
EBIT
Estimate
--18.97%
Net Income
Estimate
35.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Apellis Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for APLS of $68.9 , with forecasts ranging from
a
low of
$39 to a high of $96 .
APLS Lowest Price Target
Wall Street Target
39 USD
62.16%
APLS Average Price Target
Wall Street Target
68.9 USD
186.52%
APLS Highest Price Target
Wall Street Target
96 USD
299.17%
REVENUE FORECAST
Revenue Forecast Chart APLS
EBIT FORECAST
EBIT Forecast Chart APLS
NET INCOME FORECAST
Net Income Chart APLS